Systematic Review of NMR-Based Metabolomics Practices in Human Disease Research

Overview

Journal Metabolites

Publisher MDPI

Date 2022 Oct 27

PMID 36295865

Authors

Katherine Huang

Natalie Thomas

Paul R Gooley

Christopher W Armstrong

Affiliations

Soon will be listed here.

Abstract

Nuclear magnetic resonance (NMR) spectroscopy is one of the principal analytical techniques for metabolomics. It has the advantages of minimal sample preparation and high reproducibility, making it an ideal technique for generating large amounts of metabolomics data for biobanks and large-scale studies. Metabolomics is a popular "omics" technology and has established itself as a comprehensive exploratory biomarker tool; however, it has yet to reach its collaborative potential in data collation due to the lack of standardisation of the metabolomics workflow seen across small-scale studies. This systematic review compiles the different NMR metabolomics methods used for serum, plasma, and urine studies, from sample collection to data analysis, that were most popularly employed over a two-year period in 2019 and 2020. It also outlines how these methods influence the raw data and the downstream interpretations, and the importance of reporting for reproducibility and result validation. This review can act as a valuable summary of NMR metabolomic workflows that are actively used in human biofluid research and will help guide the workflow choice for future research.

Citing Articles

Matrix Linear Models for Connecting Metabolite Composition to Individual Characteristics.

Farage G, Zhao C, Choi H, Garrett T, Elam M, Kechris K Metabolites. 2025; 15(2).

PMID: 39997765 PMC: 11857268. DOI: 10.3390/metabo15020140.

Harnessing NMR technology for enhancing field crop improvement: applications, challenges, and future perspectives.

Gautam V, Garg V, Meena N, Kumari S, Patel S, Mukesh Metabolomics. 2025; 21(2):27.

PMID: 39979661 DOI: 10.1007/s11306-025-02229-z.

Relevance of proteomics and metabolomics approaches to overview the tumorigenesis and better management of cancer.

Singh P, Dhir Y, Gupta S, Kaushal A, Kala D, Nagraiik R 3 Biotech. 2025; 15(3):58.

PMID: 39949840 PMC: 11813842. DOI: 10.1007/s13205-025-04222-8.

Machine learning and multi-omics in precision medicine for ME/CFS.

Huang K, Lidbury B, Thomas N, Gooley P, Armstrong C J Transl Med. 2025; 23(1):68.

PMID: 39810236 PMC: 11731168. DOI: 10.1186/s12967-024-05915-z.

A-SIMA/A-MAP: a comprehensive toolkit for NMR-based metabolomics analysis.

Chiu A, Rahimi M, Lee W Metabolomics. 2024; 21(1):10.

PMID: 39702618 DOI: 10.1007/s11306-024-02208-w.

References

Neto M, Verdi G, Veras A, de Oliveira Veras M, Caetano L, Ursulino J . USE OF METABOLOMICS TO THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE. Arq Gastroenterol. 2020; 57(3):311-315. DOI: 10.1590/S0004-2803.202000000-57. View

Parra S, Lopez-Dupla M, Ibarretxe D, de Las Heras M, Amigo N, Catala A . Patients With Systemic Lupus Erythematosus Show an Increased Arterial Stiffness That is Predicted by IgM Anti-β -Glycoprotein I and Small Dense High-Density Lipoprotein Particles. Arthritis Care Res (Hoboken). 2018; 71(1):116-125. DOI: 10.1002/acr.23594. View

Vroegindewey M, van den Berg V, Oemrawsingh R, Kardys I, Asselbergs F, van der Harst P . High-frequency metabolite profiling and the incidence of recurrent cardiac events in patients with post-acute coronary syndrome. Biomarkers. 2020; 25(3):235-240. DOI: 10.1080/1354750X.2020.1731762. View

Tsai C, Lin C, Kang C, Liao C, Wang W, Chiang M . Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma. J Clin Med. 2020; 9(4). PMC: 7230778. DOI: 10.3390/jcm9040951. View

Ahmed S, Dubey D, Chowdhury A, Chaurasia S, Guleria A, Kumar S . Nuclear magnetic resonance-based metabolomics reveals similar metabolomics profiles in undifferentiated peripheral spondyloarthritis and reactive arthritis. Int J Rheum Dis. 2019; 22(4):725-733. DOI: 10.1111/1756-185X.13490. View

Lee J, Kim S, Chun Y, Chun Y, Shin S, Choi C . Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using H-NMR coupled with multivariate statistical analysis. Neurogastroenterol Motil. 2020; 32(6):e13830. DOI: 10.1111/nmo.13830. View

West K, Kanu C, Maric T, McDonald J, Nicholson J, Li J . Longitudinal metabolic and gut bacterial profiling of pregnant women with previous bariatric surgery. Gut. 2020; 69(8):1452-1459. PMC: 7398482. DOI: 10.1136/gutjnl-2019-319620. View

Lopez-Garrido L, Banuelos-Hernandez A, Perez-Hernandez E, Tecualt-Gomez R, Quiroz-Williams J, Ariza-Castolo A . Metabolic profiling of serum in patients with cartilage tumours using H-NMR spectroscopy: A pilot study. Magn Reson Chem. 2019; 58(1):65-76. DOI: 10.1002/mrc.4925. View

Meoni G, Lorini S, Monti M, Madia F, Corti G, Luchinat C . The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy. Sci Rep. 2019; 9(1):4128. PMC: 6412048. DOI: 10.1038/s41598-019-40028-4. View

10.

Dieterle F, Ross A, Schlotterbeck G, Senn H . Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem. 2006; 78(13):4281-90. DOI: 10.1021/ac051632c. View

11.

Fraser D, Slessarev M, Martin C, Daley M, Patel M, Miller M . Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Crit Care Explor. 2020; 2(10):e0272. PMC: 7587450. DOI: 10.1097/CCE.0000000000000272. View

12.

Kumari S, Kumaran S, Goyal V, Sharma R, Sinha N, Dwivedi S . Identification of potential urine biomarkers in idiopathic parkinson's disease using NMR. Clin Chim Acta. 2020; 510:442-449. DOI: 10.1016/j.cca.2020.08.005. View

13.

Chashmniam S, Kalantari S, Nafar M, Boroumandnia N . THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY. Rev Invest Clin. 2019; 71(2):106-115. DOI: 10.24875/RIC.18002668. View

14.

Klein C, Kjolhede Holle S, Andersen M, Pedersen A, Bundgaard H, Iversen K . In-hospital metabolite changes in infective endocarditis-a longitudinal H NMR-based study. Eur J Clin Microbiol Infect Dis. 2019; 38(8):1553-1560. DOI: 10.1007/s10096-019-03586-z. View

15.

Zacharias H, Altenbuchinger M, Schultheiss U, Samol C, Kotsis F, Poguntke I . A Novel Metabolic Signature To Predict the Requirement of Dialysis or Renal Transplantation in Patients with Chronic Kidney Disease. J Proteome Res. 2019; 18(4):1796-1805. DOI: 10.1021/acs.jproteome.8b00983. View

16.

Ludwig C, Viant M . Two-dimensional J-resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem Anal. 2009; 21(1):22-32. DOI: 10.1002/pca.1186. View

17.

Emwas A, Roy R, McKay R, Ryan D, Brennan L, Tenori L . Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis. J Proteome Res. 2016; 15(2):360-73. PMC: 4865177. DOI: 10.1021/acs.jproteome.5b00885. View

18.

Casadei-Gardini A, Del Coco L, Marisi G, Conti F, Rovesti G, Ulivi P . H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. Cancers (Basel). 2020; 12(1). PMC: 7016798. DOI: 10.3390/cancers12010241. View

19.

Paglia G, Del Greco F, Sigurdsson B, Rainer J, Volani C, Hicks A . Influence of collection tubes during quantitative targeted metabolomics studies in human blood samples. Clin Chim Acta. 2018; 486:320-328. DOI: 10.1016/j.cca.2018.08.014. View

20.

Wishart D . Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016; 15(7):473-84. DOI: 10.1038/nrd.2016.32. View